Highly active anti-hepatitis C therapy: Seven lessons from HIV

David L. Thomas

doi:10.3851/IMP2429

Highly active anti-hepatitis C therapy: Seven lessons from HIV

David L. Thomas

School of Medicine

Research output: Contribution to journal › Review article › peer-review

3 Scopus citations

Abstract

The HCV direct-acting antiviral treatment era is underway. Although there are some important differences, it is likely that the experience with HCV will be similar in many respects to what already occurred with HIV. This paper considers seven important lessons learned with HIV and the degree to which they should be anticipated with HCV.

Original language	English (US)
Pages (from-to)	1183-1188
Number of pages	6
Journal	Antiviral therapy
Volume	17
Issue number	6 PART B
DOIs	https://doi.org/10.3851/IMP2429
State	Published - 2012

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)
Infectious Diseases

Access to Document

10.3851/IMP2429

Cite this

@article{2a21f1e97e2342d787381c6baac391b1,

title = "Highly active anti-hepatitis C therapy: Seven lessons from HIV",

abstract = "The HCV direct-acting antiviral treatment era is underway. Although there are some important differences, it is likely that the experience with HCV will be similar in many respects to what already occurred with HIV. This paper considers seven important lessons learned with HIV and the degree to which they should be anticipated with HCV.",

author = "Thomas, {David L.}",

year = "2012",

doi = "10.3851/IMP2429",

language = "English (US)",

volume = "17",

pages = "1183--1188",

journal = "Antiviral therapy",

issn = "1359-6535",

publisher = "International Medical Press Ltd",

number = "6 PART B",

}

TY - JOUR

T1 - Highly active anti-hepatitis C therapy

T2 - Seven lessons from HIV

AU - Thomas, David L.

PY - 2012

Y1 - 2012

N2 - The HCV direct-acting antiviral treatment era is underway. Although there are some important differences, it is likely that the experience with HCV will be similar in many respects to what already occurred with HIV. This paper considers seven important lessons learned with HIV and the degree to which they should be anticipated with HCV.

AB - The HCV direct-acting antiviral treatment era is underway. Although there are some important differences, it is likely that the experience with HCV will be similar in many respects to what already occurred with HIV. This paper considers seven important lessons learned with HIV and the degree to which they should be anticipated with HCV.

UR - http://www.scopus.com/inward/record.url?scp=84867258226&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867258226&partnerID=8YFLogxK

U2 - 10.3851/IMP2429

DO - 10.3851/IMP2429

M3 - Review article

C2 - 23186629

AN - SCOPUS:84867258226

SN - 1359-6535

VL - 17

SP - 1183

EP - 1188

JO - Antiviral therapy

JF - Antiviral therapy

IS - 6 PART B

ER -

Highly active anti-hepatitis C therapy: Seven lessons from HIV

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this